Antiviral protection and germinal center formation, but impaired B cell memory in the absence of CD19

被引:58
作者
Fehr, T
Rickert, RC
Odermatt, B
Roes, J
Rajewsky, K
Hengartner, H
Zinkernagel, RM
机构
[1] Univ Zurich Hosp, Dept Pathol, Inst Expt Immunol, CH-8091 Zurich, Switzerland
[2] Univ Cologne, Inst Genet, D-50931 Cologne, Germany
关键词
CD19; antiviral immunity; complement; germinal center; B cell memory;
D O I
10.1084/jem.188.1.145
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Coligation of CD19, a molecule expressed during all stages of B cell development except plasmacytes, lowers the threshold for B cell activation with anti-IgM by a factor of 100. The cytoplasmic tail of CD19 contains nine tyrosine residues as possible phosphorylation sites and is postulated to function as the signal transducing element for complement receptor (CR)2. Generation and analysis of CD19 gene-targeted mice revealed that T cell-dependent (TD) antibody responses to proteinaceous antigens were impair-ed, whereas those to T cell-independent (TI) type 2 antigens were normal or even augmented. These results are compatible with earlier complement depletion studies and the postulated function of CD19. To analyze the role of CD19 in antiviral antibody responses, we immunized CD19(-/-) mice with viral antigens of TI-1, TI-2, and TD type. The effect of CD19 on TI responses was more dependent oil antigen dose and replicative capacity than on antigen type. CR blocking experiments confirmed the role of CD19 as B cell signal transducer for complement. In contrast to immunization with protein antigens, infection of CD19(-/-) mice with replicating virus led to generation of specific germinal centers, which persisted for >100 d, whereas maintenance of memory antibody titers as well as circulating memory B cells was fully dependent on CD19. Thus, our study confirms a costimulatory role of CD19 on B cells under limiting antigen conditions and indicates an important role for B cell memory.
引用
收藏
页码:145 / 155
页数:11
相关论文
共 74 条
[31]  
KANSAS GS, 1991, J IMMUNOL, V147, P4094
[32]   In situ studies of the germinal center reaction [J].
Kelsoe, G .
ADVANCES IN IMMUNOLOGY, VOL 60, 1995, 60 :267-288
[33]  
KLAUS GGB, 1977, IMMUNOLOGY, V33, P31
[34]  
KoscoVilbois MH, 1997, IMMUNOL TODAY, V18, P225
[35]   Self-renewal of B-1 lymphocytes is dependent on CD19 [J].
Krop, I ;
deFougerolles, AR ;
Hardy, RR ;
Allison, M ;
Schlissel, MS ;
Fearon, DT .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (01) :238-242
[36]   Alteration of B-cell antigen receptor signaling by CD19 co-ligation - A study with bispecific antibodies [J].
Lankester, AC ;
Rood, PML ;
vanSchijndel, GMW ;
Hooibrink, B ;
Verhoeven, AJ ;
vanLier, RAW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (37) :22326-22330
[37]  
LEIST TP, 1987, J IMMUNOL, V138, P2278
[38]  
LIU YJ, 1992, EUR J IMMUNOL, V22, P615
[39]   SITES OF SPECIFIC B-CELL ACTIVATION IN PRIMARY AND SECONDARY RESPONSES TO T-CELL-DEPENDENT AND T-CELL-INDEPENDENT ANTIGENS [J].
LIU, YJ ;
ZHANG, J ;
LANE, PJL ;
CHAN, EYT ;
MACLENNAN, ICM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1991, 21 (12) :2951-2962
[40]   CD19 HAS A POTENTIAL CD77 (GLOBOTRIAOSYL CERAMIDE)-BINDING SITE WITH SEQUENCE SIMILARITY TO VEROTOXIN B-SUBUNITS - IMPLICATIONS OF MOLECULAR MIMICRY FOR B-CELL ADHESION AND ENTEROHEMORRHAGIC ESCHERICHIA-COLI PATHOGENESIS [J].
MALONEY, MD ;
LINGWOOD, CA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (01) :191-201